In this video, Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine, highlighted Diana Do’s comparisons in anti-VEGF efficacy at the virtual American Academy of Ophthalmology annual meeting.
“With the advent of the newer anti-VEGF agents that have come out this year and last few years, I'm interested to see how what data she presents on how they stack up against each other,” Singh said. “From a clinical side, I feel that there are some differences in some of these drugs, albeit some
Uncategorized